Philip J. Privitera

Title
InstitutionMedical University of South Carolina
DepartmentCell and Molecular Pharmacology and Experimental Therapeutics
AddressP.O. Box MSC 505
332
173 Ashley Ave.
Phone843-792-2471
Fax843-792-2475
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Privitera PJ, Beckstead RM, Yates P, Walgren R. Autoradiographic localization of [125I-Tyr0]bradykinin binding sites in brains of Wistar-Kyoto and spontaneously hypertensive rats. Cell Mol Neurobiol. 2003 Oct; 23(4-5):805-15. PMID: 14514033.
      Citations:    
    2. Morinelli TA, Meier GP, Webb JG, Jaffa AA, Privitera PJ, Margolius HS. Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin). Int Immunopharmacol. 2002 Dec; 2(13-14):1995-2003. PMID: 12489813.
      Citations:    
    3. Morinelli TA, Webb JG, Jaffa AA, Privitera PJ, Margolius HS. A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats. J Pharmacol Exp Ther. 2001 Jan; 296(1):71-6. PMID: 11123364.
      Citations:    
    4. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 8750968.
      Citations:    
    5. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 4394473.
      Citations:    
    6. Khan IM, Miller DH, Strickland J, Margolius HS, Privitera PJ. Brain kallikrein-kinin system abnormalities in spontaneously hypertensive rats. Hypertension. 1995 Apr; 25(4 Pt 1):524-30. PMID: 7721393.
      Citations:    
    7. Privitera PJ, Thibodeaux H, Yates P. Rostral ventrolateral medulla as a site for the central hypertensive action of kinins. Hypertension. 1994 Jan; 23(1):52-8. PMID: 7904256.
      Citations:    
    8. Khan IM, Yamaji I, Miller DH, Margolius HS, Privitera PJ. Cerebrospinal fluid kallikrein in spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 1993 Oct; 11(10):1039-45. PMID: 8258667.
      Citations:    
    9. Privitera PJ, Daum PR, Hill DR, Hiley CR. Autoradiographic visualization and characteristics of [125I]bradykinin binding sites in guinea pig brain. Brain Res. 1992 Apr 10; 577(1):73-9. PMID: 1325859.
      Citations:    
    10. Privitera PJ. Brain kallikrein-kinin system in arterial pressure regulation. Agents Actions Suppl. 1992; 38 ( Pt 3):39-46. PMID: 1334359.
      Citations:    
    11. Pearson AA, Gaffney TE, Walle T, Privitera PJ. A stereoselective central hypotensive action of atenolol. J Pharmacol Exp Ther. 1989 Sep; 250(3):759-63. PMID: 2778713.
      Citations:    
    12. Walle UK, Thibodeaux H, Privitera PJ, Walle T. Stereochemistry of tissue distribution of racemic propranolol in the dog. Chirality. 1989; 1(3):192-6. PMID: 2642048.
      Citations:    
    13. Privitera PJ, Granata AR, Underwood MD, Gaffney TE, Reis DJ. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol. J Pharmacol Exp Ther. 1988 Aug; 246(2):529-33. PMID: 3404445.
      Citations:    
    14. Thomas GR, Thibodeaux H, Margolius HS, Webb JG, Privitera PJ. Afferent vagal stimulation, vasopressin, and nitroprusside alter cerebrospinal fluid kinin. Am J Physiol. 1987 Jul; 253(1 Pt 2):R136-41. PMID: 3605378.
      Citations:    
    15. Tackett RL, Webb JG, Privitera PJ. Site and mechanism of the centrally mediated hypotensive action of propranolol. J Pharmacol Exp Ther. 1985 Oct; 235(1):66-70. PMID: 4045728.
      Citations:    
    16. Hsu CY, Hogan EL, Wingfield W, Webb JG, Perot PL, Privitera PJ, Talbert OR, Balentine JD. Orthostatic hypotension with brainstem tumors. Neurology. 1984 Sep; 34(9):1137-43. PMID: 6087207.
      Citations:    
    17. Thomas GR, Thibodeaux H, Margolius HS, Privitera PJ. Cerebrospinal fluid kinins and cardiovascular function. Effects of cerebroventricular melittin. Hypertension. 1984 Mar-Apr; 6(2 Pt 2):I46-50. PMID: 6202636.
      Citations:    
    18. Fagan TC, Walle T, Corns-Hurwitz R, Conradi EC, Privitera P, Harmon G, Degenhart W, Gaffney TE. Time course of development of the antihypertensive effect of propranolol. Hypertension. 1983 Nov-Dec; 5(6):852-7. PMID: 6360868.
      Citations:    
    19. Russell MP, Webb JG, Walle T, Daniell HB, Privitera PJ, Gaffney TE. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther. 1983 Aug; 226(2):324-9. PMID: 6875845.
      Citations:    
    20. Hohn AR, Riopel DA, Keil JE, Loadholt CB, Margolius HS, Halushka PV, Privitera PJ, Webb JG, Medley ES, Schuman SH, Rubin MI, Pantell RH, Braunstein ML. Childhood familial and racial differences in physiologic and biochemical factors related to hypertension. Hypertension. 1983 Jan-Feb; 5(1):56-70. PMID: 6336720.
      Citations:    
    21. Newman WH, Webb JG, Privitera PJ. Persistence of myocardial failure following removal of chronic volume overload. Am J Physiol. 1982 Dec; 243(6):H876-83. PMID: 6756171.
      Citations:    
    22. Wilson TW, Loadholt CB, Privitera PJ, Halushka PV. Furosemide increases urine 6-keto-prostaglandin F1 alpha. Relation to natriuresis, vasodilation, and renin release. Hypertension. 1982 Sep-Oct; 4(5):634-41. PMID: 7049918.
      Citations:    
    23. Privitera PJ, Walle T, Gaffney TE. Nicotinic-like effects and tissue disposition of isopropylamine. J Pharmacol Exp Ther. 1982 Jul; 222(1):116-21. PMID: 7086693.
      Citations:    
    24. Russel MP, Privitera PJ, Walle T, Peet NP, Halushka PV, Gaffney TE. Cardiovascular effects of a 4'-methylthio analog of propranolol. J Pharmacol Exp Ther. 1981 Dec; 219(3):685-90. PMID: 6117655.
      Citations:    
    25. Tackett RL, Webb JG, Privitera PJ. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Science. 1981 Aug 21; 213(4510):911-3. PMID: 7256285.
      Citations:    
    26. Privitera PJ, Webb JG, Walle T. Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure. Eur J Pharmacol. 1979 Feb 15; 54(1-2):51-60. PMID: 421742.
      Citations:    
    27. Daniell HB, Webb JG, Privitera PJ. Studies of the interrelationship between plasma norepinephrine, plasma renin activity and acute myocardial infarction in dogs. Res Commun Chem Pathol Pharmacol. 1978 May; 20(2):289-302. PMID: 674817.
      Citations:    
    28. Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med. 1977 Sep; 87(3):281-6. PMID: 900671.
      Citations:    
    29. Saelens DA, Walle T, Gaffney TE, Privitera PJ. Studies on the contribution of active metabolites to the anticonvulsant effects of propranolol. Eur J Pharmacol. 1977 Mar 07; 42(1):39-46. PMID: 844488.
      Citations:    
    30. Daniell HB, Privitera PJ, Conradi SE, Gaffney TE. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction. J Pharmacol Exp Ther. 1977 Jan; 200(1):155-65. PMID: 833755.
      Citations:    
    31. Sealens DA, Walle T, Privitera PJ. Quantitative determination of propranolol, propranolol glycol and N-desisopropylpropranolol in brain tissue by electron capture gas chromatography. J Chromatogr. 1976 Jul 21; 123(1):185-92. PMID: 950351.
      Citations:    
    32. Gaffney TE, Knapp D, Walle T, Privitera P, Saelens D. The importance of stable isotope labelled drugs in clinical pharmacology: with illustrations from studies on the disposition of propranolol and nortriptyline in man. South Med J. 1974 Aug; 67(8):990-1002. PMID: 4854875.
      Citations:    
    33. Ishizaki T, Privitera PJ, Walle T, Gaffney TE. Cardiovascular actions of a new metabolite of propranolol: isopropylamine. J Pharmacol Exp Ther. 1974 Jun; 189(3):626-32. PMID: 4152314.
      Citations:    
    34. Saelens DA, Walle T, Privitera PJ, Knapp DR, Gaffney T. Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol. J Pharmacol Exp Ther. 1974 Jan; 188(1):86-92. PMID: 4809279.
      Citations:    
    35. Saelens DA, Walle T, Privitera PJ, Knapp DR, Gaffney T. The psychopharmacological effects of a new metabolite of propranolol. Adv Biochem Psychopharmacol. 1973; 7:107-12. PMID: 4742801.
      Citations:    
    36. Privitera PJ, Blickenstaff T, Gaffney TE, Mohammed S. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197). J Pharmacol Exp Ther. 1971 Mar; 176(3):655-61. PMID: 4398744.
      Citations:    
    37. Mohammed S, Fasola AF, Privitera PJ, Lipicky RJ, Martz BL, Gaffney TE. Effect of methyldopa on plasma renin activity in man. Circ Res. 1969 Nov; 25(5):543-8. PMID: 4900604.
      Citations:    
    38. Privitera PJ, Loggie JM, Gaffney TE. A comparison of the cardiovascular effects of biogenic amines and their precursors in newborn and adult dogs. J Pharmacol Exp Ther. 1969 Apr; 166(2):293-8. PMID: 5776987.
      Citations:    
    39. Loggie JM, Privitera PJ, Sugarman S, Gaffney TE. Effects of hydrocortisone on survival in neonatal beagles given endotoxin. Proc Soc Exp Biol Med. 1968 May; 128(1):326-9. PMID: 4872227.
      Citations:    
    40. Privitera PJ, Rosenblum I. Cardiovascular and myocardial metabolic effects of infusions of phenylephrine. J Pharmacol Exp Ther. 1967 May; 156(2):325-30. PMID: 6026262.
      Citations:    
    Privitera's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (219)
    Explore
    _
    Co-Authors (4)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _